Huge shortages of estradiol patches

alert shortage warning
Transdermal patches from both Novartis and Bayer are experiencing a shortfall, predicted to last until November While the shortages to the Novartis products have been occurring since November last year due to manufacturing reasons, the TGA has now announced current and anticipated shortages of Bayer’s Climara 25 Transdermal Patches due to “unexpected increase in demand".

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous This may not be the 'biggest flu season on record', but it is a big one – here are some possible reasons
Next PrEP listing decision deferred